Risk of severe and life-threatening diarrhea and mucositis in cancer patients receiving anti-EGFR monoclonal antibodies: a systematic review and meta-analysis of published and unpublished data
Risk of severe and life-threatening diarrhea and mucositis in cancer patients receiving anti-EGFR monoclonal antibodies: a systematic review and meta-analysis of published and unpublished data
MIRODDI, MARCO
2017-12-18
Abstract
Risk of severe and life-threatening diarrhea and mucositis in cancer patients receiving anti-EGFR monoclonal antibodies: a systematic review and meta-analysis of published and unpublished dataFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Tesi dottorato Miroddi_Finale (1).pdf
accesso aperto
Descrizione: Tesi di Dottorato
Tipologia:
Versione Editoriale (PDF)
Dimensione
924.28 kB
Formato
Adobe PDF
|
924.28 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
